Kim H, Scimia MC, Wilkinson D, Trelles RD, Wood MR, Bowtell D, et al
With all this in mind, if you are considering taking a GLP-1 medication, talk to your healthcare provider about being prescribed one that's FDA-approved instead of falling for the clever marketing of GLP-1 patches
In addition, a selective GIP agonist showed very low effectiveness in reducing weight, while this co-agonist showed synergism in reducing fat mass in obese rodents
10.3389/fphys.2018.01622 Summary Keywords dipeptidyl peptidase-4, glucagon-like peptide-1, incretin, peptide degradation, therapy, type 2 diabetes Citation Deacon CF (2019) Physiology and Pharmacology of DPP-4 in Glucose Homeostasis and the Treatment of Type 2 Diabetes